Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1983 1
1984 1
1985 3
1986 2
1987 1
1988 4
1989 3
1990 2
1991 1
1992 3
1994 1
1995 2
1996 5
1997 4
1998 3
1999 6
2000 8
2001 12
2002 8
2003 5
2004 14
2005 11
2006 16
2007 7
2008 7
2009 7
2010 12
2011 15
2012 12
2013 12
2014 11
2015 8
2016 17
2017 18
2018 18
2019 7
2020 7
2021 8
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

265 results
Results by year
Filters applied: . Clear all
Page 1
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. Travis WD, et al. Among authors: huber rm. J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. J Thorac Oncol. 2011. PMID: 21252716 Free PMC article. Review.
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.
Kim DW, Tiseo M, Ahn MJ, Reckamp KL, Hansen KH, Kim SW, Huber RM, West HL, Groen HJM, Hochmair MJ, Leighl NB, Gettinger SN, Langer CJ, Paz-Ares Rodríguez LG, Smit EF, Kim ES, Reichmann W, Haluska FG, Kerstein D, Camidge DR. Kim DW, et al. Among authors: huber rm. J Clin Oncol. 2017 Aug 1;35(22):2490-2498. doi: 10.1200/JCO.2016.71.5904. Epub 2017 May 5. J Clin Oncol. 2017. PMID: 28475456 Free article. Clinical Trial.
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial.
Huber RM, Hansen KH, Paz-Ares Rodríguez L, West HL, Reckamp KL, Leighl NB, Tiseo M, Smit EF, Kim DW, Gettinger SN, Hochmair MJ, Kim SW, Langer CJ, Ahn MJ, Kim ES, Kerstein D, Groen HJM, Camidge DR. Huber RM, et al. J Thorac Oncol. 2020 Mar;15(3):404-415. doi: 10.1016/j.jtho.2019.11.004. Epub 2019 Nov 19. J Thorac Oncol. 2020. PMID: 31756496 Free article. Clinical Trial.
[Lung cancer].
Huber RM, Tufman A. Huber RM, et al. Dtsch Med Wochenschr. 2014 Mar;139(11):545-52; quiz 553-6. doi: 10.1055/s-0033-1349593. Epub 2014 Mar 4. Dtsch Med Wochenschr. 2014. PMID: 24595713 Review. German. No abstract available.
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).
Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier JP, Varela G, Licker M, Ferguson MK, Faivre-Finn C, Huber RM, Clini EM, Win T, De Ruysscher D, Goldman L; European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. Brunelli A, et al. Among authors: huber rm. Eur Respir J. 2009 Jul;34(1):17-41. doi: 10.1183/09031936.00184308. Eur Respir J. 2009. PMID: 19567600 Free article.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS. Rizvi NA, et al. Among authors: huber rm. Lancet Oncol. 2015 Mar;16(3):257-65. doi: 10.1016/S1470-2045(15)70054-9. Epub 2015 Feb 20. Lancet Oncol. 2015. PMID: 25704439 Free PMC article. Clinical Trial.
[Lung cancer].
Huber RM. Huber RM. Internist (Berl). 2006 Jun;47(6):611-20; quiz 621. doi: 10.1007/s00108-006-1581-3. Internist (Berl). 2006. PMID: 16767476 Review. German.
[Quality assurance].
Flentje M, Hoffmann H, Huber RM. Flentje M, et al. Among authors: huber rm. Onkologie. 2012;35 Suppl 3:14-6. doi: 10.1159/000338990. Epub 2012 May 15. Onkologie. 2012. PMID: 22678020 Free article. German. No abstract available.
[Foreword].
Gatzemeier U, Griesinger F, Huber RM, Thomas M. Gatzemeier U, et al. Among authors: huber rm. Onkologie. 2008;31 Suppl 3:V. doi: 10.1159/000128573. Onkologie. 2008. PMID: 18545001 Free article. German. No abstract available.
265 results